Clinical experiences with trandolapril

Am Heart J. 1993 May;125(5 Pt 2):1542-6. doi: 10.1016/0002-8703(93)90453-g.

Abstract

In this article the clinical experiences with the new non-sulfhydryl angiotensin-converting enzyme inhibitor trandolapril are reviewed. The drug lowers blood pressure effectively in patients with mild-to-severe hypertension including elderly and obese patients. Distinguishing features of the compound are its long plasma half-life and high degree of lipophilicity.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Hypertension / drug therapy*
  • Indoles / therapeutic use*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Indoles
  • trandolapril